Do analysts rate TLRY or BHC?

Tilray Brands currently has a consensus target price of C$13.30, indicating a potential upside of 129.31%. Given Tilray Brands' higher probable upside, research analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate MJN or TLRY?

Tilray Brands has a consensus target price of C$13.30, indicating a potential upside of 129.31%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger valuation and earnings, MJN or TLRY?

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group N/A N/A N/A N/A N/A Tilray Brands C$915.45M 0.89 -C$183.24M -C$1.09 N/A

Which has better earnings & valuation, CRON or TLRY?

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group C$179.09M 9.90 -C$32.78M C$0.19 25.32 Tilray Brands C$915.45M 0.89 -C$183.24M -C$1.09 N/A

Do analysts recommend TLRY or CARA?

Tilray Brands currently has a consensus price target of C$13.30, suggesting a potential upside of 129.31%. Given Tilray Brands' stronger consensus rating and higher probable upside, equities analysts plainly believe Tilray Brands is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation and earnings, TLRY or CARA?

Cara Operations has lower revenue, but higher earnings than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tilray Brands C$915.45M 0.89 -C$183.24M -C$1.09 N/A Cara Operations N/A N/A N/A N/A N/A

Tilray Brands (TLRY) Competitors

C$5.80 -0.16 (-2.68%)

As of 09/23/2026 04:00 PM Eastern

Compare

TLRY vs. BHC, MJN, CRON, CARA, and GUD

Should you buy Tilray Brands stock or one of its competitors? Tilray Brands's main competitors and comparable companies include Bausch Health Companies (BHC), Cronos Group (MJN), Cronos Group (CRON), Cara Operations (CARA), and Knight Therapeutics (GUD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Tilray Brands compare to Bausch Health Companies?

Tilray Brands (TSE:TLRY) and Bausch Health Companies (TSE:BHC) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

In the previous week, Bausch Health Companies' average media sentiment score of 0.21 beat Tilray Brands' score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company	Overall Sentiment
Tilray Brands	Neutral
Bausch Health Companies	Neutral

5.6% of Tilray Brands shares are held by institutional investors. Comparatively, 9.7% of Bausch Health Companies shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Tilray Brands has a beta of 3.215277, suggesting that its share price is 222% more volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.707626, suggesting that its share price is 29% less volatile than the broader market.

Bausch Health Companies has higher revenue and earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$915.45M	0.89	-C$183.24M	-C$1.09	N/A
Bausch Health Companies	C$10.85B	0.28	-C$125.65M	-C$2.94	N/A

Bausch Health Companies has a net margin of -12.02% compared to Tilray Brands' net margin of -15.22%. Bausch Health Companies' return on equity of 87.57% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-15.22%	-8.85%	-1.41%
Bausch Health Companies	-12.02%	87.57%	4.16%

Tilray Brands currently has a consensus target price of C$13.30, indicating a potential upside of 129.31%. Given Tilray Brands' higher probable upside, research analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Bausch Health Companies beats Tilray Brands on 9 of the 13 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Cronos Group (CVE:MJN) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

5.6% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Tilray Brands has a consensus target price of C$13.30, indicating a potential upside of 129.31%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has higher earnings, but lower revenue than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	N/A	N/A	N/A	N/A	N/A
Tilray Brands	C$915.45M	0.89	-C$183.24M	-C$1.09	N/A

Cronos Group has a net margin of 0.00% compared to Tilray Brands' net margin of -15.22%. Cronos Group's return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	N/A	N/A	N/A
Tilray Brands	-15.22%	-8.85%	-1.41%

In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Tilray Brands'average media sentiment score.

Company	Overall Sentiment
Cronos Group	Neutral
Tilray Brands	Neutral

Summary

Tilray Brands beats Cronos Group on 5 of the 8 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Cronos Group (TSE:CRON) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

4.3% of Cronos Group shares are owned by institutional investors. Comparatively, 5.6% of Tilray Brands shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cronos Group has a beta of 1.29991, meaning that its stock price is 30% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.215277, meaning that its stock price is 222% more volatile than the broader market.

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$179.09M	9.90	-C$32.78M	C$0.19	25.32
Tilray Brands	C$915.45M	0.89	-C$183.24M	-C$1.09	N/A

Cronos Group presently has a consensus price target of C$4.92, indicating a potential upside of 2.22%. Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 129.31%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has a net margin of 38.95% compared to Tilray Brands' net margin of -15.22%. Cronos Group's return on equity of 6.46% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	38.95%	6.46%	-3.73%
Tilray Brands	-15.22%	-8.85%	-1.41%

In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Tilray Brands'average media sentiment score.

Company	Overall Sentiment
Cronos Group	Neutral
Tilray Brands	Neutral

Summary

Cronos Group beats Tilray Brands on 9 of the 14 factors compared between the two stocks.

How does Tilray Brands compare to Cara Operations?

Tilray Brands (TSE:TLRY) and Cara Operations (TSE:CARA) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -15.22%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-15.22%	-8.85%	-1.41%
Cara Operations	N/A	N/A	N/A

In the previous week, Tilray Brands' average media sentiment score of 0.00 equaled Cara Operations'average media sentiment score.

Company	Overall Sentiment
Tilray Brands	Neutral
Cara Operations	Neutral

Tilray Brands currently has a consensus price target of C$13.30, suggesting a potential upside of 129.31%. Given Tilray Brands' stronger consensus rating and higher probable upside, equities analysts plainly believe Tilray Brands is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Cara Operations has lower revenue, but higher earnings than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$915.45M	0.89	-C$183.24M	-C$1.09	N/A
Cara Operations	N/A	N/A	N/A	N/A	N/A

5.6% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Tilray Brands beats Cara Operations on 5 of the 8 factors compared between the two stocks.

How does Tilray Brands compare to Knight Therapeutics?

Knight Therapeutics (TSE:GUD) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Knight Therapeutics has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Knight Therapeutics	C$547.31M	1.81	-C$30.73M	C$0.15	67.27
Tilray Brands	C$915.45M	0.89	-C$183.24M	-C$1.09	N/A

Knight Therapeutics has a net margin of 2.72% compared to Tilray Brands' net margin of -15.22%. Knight Therapeutics' return on equity of 1.91% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Knight Therapeutics	2.72%	1.91%	0.51%
Tilray Brands	-15.22%	-8.85%	-1.41%

In the previous week, Knight Therapeutics had 1 more articles in the media than Tilray Brands. MarketBeat recorded 1 mentions for Knight Therapeutics and 0 mentions for Tilray Brands. Knight Therapeutics' average media sentiment score of 0.00 equaled Tilray Brands'average media sentiment score.

Company	Overall Sentiment
Knight Therapeutics	Neutral
Tilray Brands	Neutral

Knight Therapeutics has a beta of -0.290935, indicating that its stock price is 129% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.215277, indicating that its stock price is 222% more volatile than the broader market.

Knight Therapeutics currently has a consensus target price of C$9.50, suggesting a potential downside of 5.85%. Tilray Brands has a consensus target price of C$13.30, suggesting a potential upside of 129.31%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Knight Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Knight Therapeutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

22.7% of Knight Therapeutics shares are owned by institutional investors. Comparatively, 5.6% of Tilray Brands shares are owned by institutional investors. 45.6% of Knight Therapeutics shares are owned by company insiders. Comparatively, 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Knight Therapeutics beats Tilray Brands on 12 of the 15 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TLRY vs. The Competition

Export

Metric	Tilray Brands	Pharmaceuticals Industry	Healthcare Sector	TSE Exchange
Market Cap	C$814.45M	C$12.60B	C$7.31B	C$12.84B
Dividend Yield	N/A	2.63%	2.52%	6.27%
P/E Ratio	-5.32	792.28	274.08	40.36
Price / Sales	0.89	862.22	638.21	9.35
Price / Cash	5.95	88.64	77.80	82.29
Price / Book	0.42	10.59	10.47	4.69
Net Income	-C$183.24M	C$2.81B	C$3.49B	C$299.09M
7 Day Performance	5.26%	-0.11%	-0.67%	0.01%
1 Month Performance	-11.85%	-1.34%	-3.17%	-2.14%
1 Year Performance	-67.23%	2.86%	15.14%	20.17%

Tilray Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TLRY Tilray Brands	1.2073 of 5 stars	C$5.80 -2.7%	C$13.30 +129.3%	-66.5%	C$814.45M	C$915.45M	N/A	3,595	News Coverage
BHC Bausch Health Companies	0.6146 of 5 stars	C$7.98 +1.3%	N/A	-13.7%	C$2.98B	C$10.85B	N/A	20,300
MJN Cronos Group	N/A	C$12.15 -1.9%	N/A	+0.0%	C$1.73B	N/A	N/A	7,600
CRON Cronos Group	1.2957 of 5 stars	C$4.62 +3.6%	C$4.92 +6.4%	+32.1%	C$1.70B	C$179.09M	24.32	610
CARA Cara Operations	N/A	N/A	N/A	N/A	C$1.62B	N/A	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:TLRY) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, MJN, CRON, CARA, and GUD

How does Tilray Brands compare to Bausch Health Companies?

Summary

How does Tilray Brands compare to Cronos Group?

Summary

How does Tilray Brands compare to Cronos Group?

Summary

How does Tilray Brands compare to Cara Operations?

Summary

How does Tilray Brands compare to Knight Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, MJN, CRON, CARA, and GUD

How does Tilray Brands compare to Bausch Health Companies?

Does the media favor TLRY or BHC?

Do insiders and institutionals have more ownership in TLRY or BHC?

Which has more risk and volatility, TLRY or BHC?

Which has higher valuation & earnings, TLRY or BHC?

Is TLRY or BHC more profitable?

Do analysts rate TLRY or BHC?

Summary

How does Tilray Brands compare to Cronos Group?

Do institutionals and insiders have more ownership in MJN or TLRY?

Do analysts rate MJN or TLRY?

Which has stronger valuation and earnings, MJN or TLRY?

Is MJN or TLRY more profitable?

Does the media prefer MJN or TLRY?

Summary

How does Tilray Brands compare to Cronos Group?

Do institutionals & insiders have more ownership in CRON or TLRY?

Which has more risk and volatility, CRON or TLRY?

Which has better earnings & valuation, CRON or TLRY?

Do analysts rate CRON or TLRY?

Is CRON or TLRY more profitable?

Does the media refer more to CRON or TLRY?

Summary

How does Tilray Brands compare to Cara Operations?

Is TLRY or CARA more profitable?

Does the media refer more to TLRY or CARA?

Do analysts recommend TLRY or CARA?

Which has better valuation and earnings, TLRY or CARA?

Do insiders and institutionals hold more shares of TLRY or CARA?

Summary

How does Tilray Brands compare to Knight Therapeutics?

Which has preferable valuation and earnings, GUD or TLRY?

Is GUD or TLRY more profitable?

Does the media refer more to GUD or TLRY?

Which has more risk & volatility, GUD or TLRY?

Do analysts prefer GUD or TLRY?

Do institutionals & insiders hold more shares of GUD or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools